v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 280,663 $ 360,382
Marketable securities 220,282 0
Prepaid expenses and other current assets 7,296 5,280
Total current assets 508,241 365,662
Property and equipment, net 98 170
Right-of-use assets, operating leases 1,642 1,930
Other assets 236 234
Total assets 510,217 367,996
Current liabilities:    
Accounts payable 4,749 12,629
Accrued external research and development expenses 10,351 1,986
Other accrued expenses 4,451 6,159
Operating lease liabilities, current 759 665
Total current liabilities 20,310 21,439
Operating lease liabilities, non-current 1,078 1,436
Total liabilities 21,388 22,875
Commitments and contingencies (Note 14)
Stockholders' equity:    
Common stock, $0.0001 par value; 100,000,000 shares authorized as of June 30, 2024 and December 31, 2023; 29,707,997 and 24,360,233 shares issued outstanding as of June 30, 2024 and December 31, 2023, respectively 3 2
Additional paid-in capital 730,832 533,764
Accumulated other comprehensive loss (60) 0
Accumulated deficit (241,946) (188,645)
Total stockholders' equity 488,829 345,121
Total liabilities and stockholders equity $ 510,217 $ 367,996